Gary K Steinberg, MD
Neurosurgery · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 18
- 4 carriers
- Office
- 1
- Since medical school
- 46 years
- Stanford University School of Medicine, 1980
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
18 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Steinberg’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
18 of 18 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G45480 · Current
Licensed to practise in California · since 1981 · expires 2028-07-31 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$133,283
Medicare paid this office $133,283 for 104 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Repair of complex aneurysm of neck artery | 14 | $52,418 | $3,495 |
| New patient visit (60+ min) | 40 | $6,198 | $155 |
| Use of operating microscope | 31 | $5,483 | $171 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $3,412 | $155 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $3,178 | $106 |
See all 7 services
| Repair of complex aneurysm of neck artery | 14 | $52,418 | $3,495 |
| New patient visit (60+ min) | 40 | $6,198 | $155 |
| Use of operating microscope | 31 | $5,483 | $171 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $3,412 | $155 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $3,178 | $106 |
| Long return visit (40+ min) | 12 | $1,566 | $130 |
| Return visit (30+ min) | 18 | $1,449 | $81 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Use of operating microscope | 24 | 27 | 37 | 27 | 31 | 32 |
| Removal of blood clot and portion of chest, neck, or brain artery | 12 | 17 | – | 16 | – | – |
| Computer-assisted procedure inside brain | – | 12 | 11 | 11 | – | – |
| Repair of complex aneurysm of neck artery | – | – | 13 | – | – | 15 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
104 Original Medicare patients in 2024. Average age 70 · Women 60% · Also on Medicaid 30% · Health risk score 1.34. At or below the middle of the specialty; the typical neurosurgery clinician is at 1.46.
Conditions among them: High blood pressure 75% · Stroke 66% · Diabetes 35% · Coronary heart disease 31% · Depression 25% · Chronic kidney disease 20% · Atrial fibrillation 20% · Heart failure 18% · Cancer 17% · COPD 13% · Dementia 13%.
The office billed $735,632, Medicare allowed $167,489 and paid $133,283; for 249 services of 29 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 104 | 249 | 70 | 1.34 | $735,632 | $133,283 |
| 2023 | 104 | 340 | 71 | 1.20 | $858,629 | $154,340 |
| 2022 | 116 | 359 | 69 | 1.13 | $687,059 | $133,937 |
| 2021 | 135 | 540 | 70 | 1.21 | $949,169 | $186,994 |
| 2020 | 104 | 309 | 70 | 1.46 | $706,773 | $131,958 |
| 2019 | 122 | 341 | 69 | 1.34 | $694,244 | $130,609 |
| 2018 | 131 | 345 | 72 | 1.60 | $842,169 | $148,316 |
| 2017 | 119 | 363 | 70 | 1.64 | $670,900 | $118,812 |
| 2016 | 125 | 291 | 69 | 1.39 | $768,692 | $133,388 |
| 2015 | 101 | 254 | 67 | 1.28 | $761,426 | $134,952 |
| 2014 | 121 | 297 | 68 | 1.24 | $899,196 | $155,110 |
| 2013 | 101 | 276 | 69 | 1.13 | $739,106 | $128,672 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $12,396 | $110 |
| New patient visit (60+ min) | 40 | $6,680 | $167 |
| Use of operating microscope | 28 | $5,663 | $183 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $3,998 | $160 |
| Return visit (30+ min) | 25 | $2,349 | $84 |
| Long return visit (40+ min) | 11 | $1,463 | $133 |
| Hospital discharge day management, 30 minutes or less | 13 | $987 | $76 |
2022: 8 services
| Removal of blood clot and portion of chest, neck, or brain artery | 14 | $15,144 | $946 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $12,498 | $94 |
| New patient visit (60+ min) | 59 | $9,474 | $161 |
| Use of operating microscope | 25 | $4,940 | $183 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,984 | $181 |
| Computer-assisted procedure inside brain | 11 | $2,175 | $198 |
| Return visit (30+ min) | 22 | $1,741 | $76 |
| Hospital discharge day management, 30 minutes or less | 16 | $1,071 | $67 |
2021: 9 services
| Repair of complex aneurysm of neck artery | 13 | $47,792 | $3,676 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 46 | $23,483 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 55 | $10,383 | $182 |
| New patient visit (60+ min) | 44 | $7,408 | $168 |
| Use of operating microscope | 35 | $6,909 | $187 |
| Return visit (30+ min) | 27 | $2,249 | $80 |
| Computer-assisted procedure inside brain | 11 | $2,222 | $202 |
| Hospital discharge day management, 30 minutes or less | 28 | $1,970 | $68 |
| Long return visit (40+ min) | 12 | $1,524 | $127 |
2020: 8 services
| Removal of blood clot and portion of chest, neck, or brain artery | 17 | $16,810 | $989 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $8,215 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $5,454 | $188 |
| Use of operating microscope | 27 | $5,060 | $187 |
| New patient visit (60+ min) | 30 | $4,650 | $155 |
| Computer-assisted procedure inside brain | 12 | $2,428 | $202 |
| Hospital discharge day management, 30 minutes or less | 22 | $1,654 | $69 |
| Short return visit (20+ min) | 27 | $1,336 | $45 |
2019: 7 services
| Removal of blood clot and portion of chest, neck, or brain artery | 11 | $11,521 | $960 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 27 | $8,490 | $94 |
| New patient visit (60+ min) | 41 | $5,950 | $145 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $5,323 | $184 |
| Use of operating microscope | 24 | $4,421 | $184 |
| Short return visit (20+ min) | 35 | $1,742 | $45 |
| Hospital discharge day management, 30 minutes or less | 24 | $1,621 | $68 |
2018: 11 services
| Removal of blood clot and portion of chest, neck, or brain artery | 19 | $17,637 | $928 |
| Use of operating microscope | 32 | $6,012 | $177 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $5,449 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $4,588 | $176 |
| New patient visit (60+ min) | 28 | $3,742 | $134 |
| Computer-assisted procedure inside brain | 13 | $2,490 | $192 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,778 | $119 |
| New patient visit (45+ min) | 15 | $1,677 | $112 |
| Short return visit (20+ min) | 32 | $1,401 | $41 |
| Hospital discharge day management, 30 minutes or less | 16 | $1,038 | $61 |
| Short return visit (20+ min) | 11 | $492 | $45 |
2017: 7 services
| Removal of blood clot and portion of chest, neck, or brain artery | 17 | $16,697 | $928 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $12,620 | $93 |
| New patient visit (60+ min) | 28 | $4,065 | $145 |
| Use of operating microscope | 20 | $3,646 | $182 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 30 | $3,605 | $116 |
| Short return visit (20+ min) | 38 | $1,682 | $42 |
| Hospital discharge day management, 30 minutes or less | 16 | $1,126 | $66 |
2016: 8 services
| Removal of blood clot and portion of chest, neck, or brain artery | 12 | $11,149 | $929 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $4,444 | $93 |
| New patient visit (60+ min) | 29 | $4,411 | $152 |
| Use of operating microscope | 23 | $4,272 | $178 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 28 | $3,402 | $121 |
| New patient visit (45+ min) | 27 | $2,863 | $106 |
| Short return visit (20+ min) | 33 | $1,577 | $44 |
| Hospital discharge day management, 30 minutes or less | 13 | $793 | $61 |
2015: 4 services
| New patient visit (60+ min) | 33 | $4,801 | $145 |
| Use of operating microscope | 22 | $4,416 | $184 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,829 | $122 |
| Short return visit (20+ min) | 32 | $1,702 | $42 |
2014: 9 services
| Removal of facial bone to approach brain lesion | 12 | $27,898 | $2,325 |
| Removal of blood clot and portion of chest, neck, or brain artery | 12 | $12,912 | $993 |
| Removal of growth or tissue of front of skull base within membranes covering brain | 12 | $11,981 | $998 |
| New patient visit (60+ min) | 51 | $7,224 | $142 |
| Use of operating microscope | 26 | $4,721 | $182 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $3,164 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $3,050 | $92 |
| Short return visit (20+ min) | 31 | $1,365 | $40 |
| Return visit (30+ min) | 11 | $699 | $64 |
2013: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $7,283 | $90 |
| New patient visit (60+ min) | 40 | $5,725 | $143 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 35 | $4,060 | $110 |
| Computer-assisted procedure inside brain | 11 | $2,127 | $193 |
| Short return visit (20+ min) | 17 | $657 | $39 |
Drugs they prescribed that Part D paid
$313
Pharmacies billed $313 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 17) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
16 generic and fewer than 11 brand-name prescriptions · $313 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 17 | None | 0% (0) | None | $313 |
| 2023 | 34 | 13 | 0% (0) | 0% | $2,855 |
| 2022 | 30 | 13 | None | 0% | $1,727 |
| 2021 | 79 | 25 | 0% (0) | None | $6,474 |
| 2020 | 112 | 39 | 0% (0) | None | $10,676 |
| 2019 | 118 | 43 | 0% (0) | None | $4,601 |
| 2018 | 120 | 41 | None | None | $1,800 |
| 2017 | 42 | 23 | None | None | $419 |
| 2016 | 38 | 23 | 0% (0) | None | $6,247 |
| 2015 | 41 | 23 | None | None | $2,892 |
| 2014 | 63 | 22 | 19% (12) | None | $3,877 |
| 2013 | 60 | 24 | 23% (14) | None | $6,933 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 1 drug
| Levetiracetam | 15 | $1,465 | $98 |
2021: 1 drug
| Dexamethasone | 11 | $70 | $6 |
2020: 3 drugs
| Midodrine | 13 | $1,140 | $88 |
| Ondansetron Odt | 24 | $175 | $7 |
| Dexamethasone | 13 | $121 | $9 |
2019: 4 drugs
| Midodrine | 17 | $1,753 | $103 |
| Ondansetron Odt | 21 | $130 | $6 |
| Famotidine | 12 | $78 | $6 |
| Dexamethasone | 15 | $72 | $5 |
2018: 4 drugs
| Polyethylene Glycol 3350 | 11 | $224 | $20 |
| Ondansetron Odt | 13 | $131 | $10 |
| Dexamethasone | 19 | $105 | $6 |
| Famotidine | 15 | $97 | $6 |
2014: 1 drug
| Hydrocodone-Acetaminophen | 12 | $105 | $9 |
2013: 1 drug
| Hydrocodone-Acetaminophen | 14 | $80 | $6 |
Money from drug and device companies
$8,823 in 2025
| 2025 | 3 | 12 | $7,500 | $8,823 |
| 2023 | 1 | 2 | $26,875 | $26,875 |
| 2022 | 2 | 4 | $42,125 | $42,125 |
| 2021 | 3 | 8 | $81,375 | $102,547 |
| 2020 | 2 | 5 | $50,625 | $50,625 |
| 2019 | 2 | 5 | $46,726 | $46,879 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Surgical Theater. | None | $7,500 | 1 payment
|
| Medical Device Business Services | None | $1,292 | 10 payments
|
| DePuy Synthes Sales | None | $30 | 1 payment
|
See all 12 published payments
| Medical Device Business Services | Meals · 2025-12-05 | None | $60 |
| Medical Device Business Services | Meals · 2025-12-05 | None | $40 |
| Medical Device Business Services | Travel · 2025-12-05 | None | $656 |
| Medical Device Business Services | Meals · 2025-12-05 | None | $138 |
| Medical Device Business Services | Meals · 2025-12-05 | None | $9 |
| Medical Device Business Services | Meals · 2025-12-04 | None | $60 |
| Medical Device Business Services | Meals · 2025-12-04 | None | $40 |
| Medical Device Business Services | Meals · 2025-12-04 | None | $18 |
| Medical Device Business Services | Travel · 2025-12-04 | None | $153 |
| Medical Device Business Services | Meals · 2025-12-03 | None | $119 |
| DePuy Synthes Sales | Meals · 2025-12-03 | None | $30 |
| Surgical Theater. | Royalties · 2025-01-17 | None | $7,500 |
See earlier years (2023, 2022, 2021, 2020, 2019)
2023: $26,875
| Surgical Theater. | None | $26,875 | 2 payments
|
2022: $42,125
| Surgical Theater. | None | $27,125 | 2 payments
|
| Carl Zeiss Meditec USA | Infrared 800 With Flow 800 Option | $15,000 | 2 payments
|
2021: $102,547
| Surgical Theater. | None | $58,875 | 2 payments
|
| Carl Zeiss Meditec USA | Kinevo | $22,500 | 4 payments
|
| Medtronic | Stealthstation | $21,172 | 2 payments
|
2020: $50,625
| Carl Zeiss Meditec | Kinevo | $27,375 | 4 payments
|
| Surgical Theater | None | $23,250 | 1 payment
|
2019: $46,879
| Carl Zeiss Meditec | Infrared 800 | $24,750 | 3 payments
|
| Medtronic USA | Aquamantys | $22,129 | 2 payments
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Sunovion Pharmaceuticals Inc. · Study of Modified Stem Cells (Sb623) in Patients With Chronic Motor Deficit From Ischemic Stroke (Actissima) · 2019 | Their institution | $208,595 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1013074277
- Licence
- CA G45480California G45480: Current · expires 2028-07-31
- Trained
- Stanford University School of Medicine, 1980 · 46 years ago
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G454800
- Taxonomy
- Federal specialty code 207T00000X (207T00000X)
- Mailing address
- 300 Pasteur Dr, Palo Alto, CA, 94305
- NPI first listed
- 2007-01-03
- NPI last updated
- 2024-04-27
- NPI record certified
- 2024-04-27
This is when the NPI record was last certified, not a medical board exam.